Call type insight
Clinical Trial Inquiries
Clinical trial inquiries come from patients who saw a study listing, heard about a trial from another physician, or were told by a relative that the practice runs research. Some callers are well informed; others are hoping for access to a treatment they cannot get elsewhere. These calls need careful handling. The caller deserves accurate information about what the practice is enrolling, eligibility is a decision for the research team, and the study protocol may limit what can be said. The practice's job on the phone is to capture interest cleanly and get it to the study coordinator without delay.
Who calls about clinical trials
- •Patients who found a study on a public registry or in an advertisement
- •Patients referred by their own physician for a specific trial
- •Family members calling on behalf of a patient with a serious illness
- •Current participants with scheduling or logistics questions
- •Sponsors, monitors and other offices asking for the study coordinator
Separating new inquiries from current participants is the first and most important routing step.
What the AI may say about a study
- •Which studies the practice is enrolling, if the research team approves that list
- •General logistics the coordinator approved, such as where study visits take place
- •That eligibility is decided by the research team after a review
- •How the screening process works, in approved wording that fits the protocol
Anything about a study beyond the approved wording waits for the coordinator.
Information the coordinator wants captured
- •Name, contact details and the best time to reach the caller
- •Which study or condition the caller is asking about
- •How the caller heard about the study, which the research team may want recorded
- •Whether a physician referred them, and which physician
- •Only pre-screening questions the research team wrote and approved for phone use, asked as written
Collecting less, but the right things, keeps the inquiry inside the protocol.
Lines the AI does not cross
- •It does not tell a caller they qualify or do not qualify for a study
- •It does not describe expected benefits, risks or outcomes of an investigational treatment
- •It does not discuss informed consent, which belongs to the study team
- •It does not advise anyone about stopping a current treatment in order to enroll
Research rules and clinical safety rules both point to a person for these decisions.
Calls from current participants
- •Requests to move a study visit go to the coordinator, since protocols often set visit windows
- •Reports of new symptoms are routed to the study team under the practice's escalation rules
- •Callers describing an emergency are told to hang up and call emergency services
- •Logistics questions are answered from the approved participant information
Participant calls can carry safety reporting duties, so their routing rules must be explicit.
What research teams can track
- •Inquiries grouped by study and by referral source
- •The wait between an inquiry and the first coordinator contact
- •Inquiries that never reached a screening visit, with the reason staff recorded
- •Questions callers ask that the approved script does not yet answer
Inquiry records help the coordinator see which outreach brings in appropriate callers.
Routing checklist
Keep this call type consistent across shifts with a short routing checklist.
- •Define required intake fields for this call type.
- •Set escalation rules and approved handoffs.
- •Confirm where summaries and tasks are logged.
- •Measure resolution time and update scripts regularly.
Frequently asked questions
Can the AI screen patients for trial eligibility?
If your research team allows phone pre-screening, the AI can ask the specific questions the team writes and approves, word for word, and record the answers. It does not decide eligibility or tell the caller whether they qualify. The coordinator reviews the responses and makes contact under the study's own process.
Is it appropriate to let AI answer calls about research?
For intake and routing it can be, provided the research team confirms the protocol allows it, approves the wording, and the AI stays inside that wording. Each call is transcribed and summarized, which gives the coordinator a clear record of what the caller asked and exactly what they were told.
What if a study participant calls about a side effect?
Symptom reports go to the study team or clinical staff under your escalation rules, and a caller describing an emergency is told to call emergency services. The AI does not assess the symptom. Your team decides how these calls are routed during and after office hours.
Bottom line
Clinical trial calls reward precision. Have the research team approve what can be said, write the few pre-screening questions that matter, and route every inquiry to the coordinator with a clean summary. Keep eligibility, consent and symptom reports with the study team, and use the inquiry records to see which outreach reaches the right patients.
More call types to explore
View all call types →Map adjacent scenarios so your routing, staffing, and automation rules stay consistent.
Phone problem guides
Map each call type to the phone problem it causes.
Explore the Phone Problems hub to see how missed calls, long holds, voicemail overflow, and staffing gaps show up in daily call patterns.
Solve the phone problem next
Turn this call type into a system-level fix
These phone-problem guides stay within two clicks so you can show leadership exactly how this scenario gets resolved end to end.
Phone problem fix
Missed calls spiral
Stop overflow before it hits voicemail with 24/7 coverage and structured intake.
Open →Front desk relief
Front desk overload playbook
Route routine calls to AI so staff can focus on in-person patients.
Open →After-hours plan
Voicemail overflow cleanup
Capture every caller after hours and deliver summaries before staff log in.
Open →